Ketamine is a dissociative drug that has been used medically since the 1970s primarily as an anesthetic agent but also for various psychiatric applications. Read full article here.
Ketamine is readily available, is inexpensive to manufacture, and has a relatively good safety profile. It is likely for these reasons that it is the most popular anesthesia drug worldwide, used to induce temporary anesthesia, amnesia, and paralysis. Read full article here.
Ketamine, A transformational Catalyst: MAPS
Ketamine is a Schedule 3 prescription drug that has been safely used in anesthesia for decades. Many years ago, it was discovered that as anesthesia wore off, patients were having unique and often disturbing psychedelic effects for which they were unprepared. Read full article here.
Ketamine may regenerate synaptic connections between brain cells damaged by stress and depression, according to new Yale-led research. Read full article here.
Over the past 50 years, ketamine has solidified its position in both human and veterinary medicine as an important anesthetic with many uses. Read full article here.
In 2019, esketamine received FDA approval as an adjunctive treatment for treatment-resistant depression (TRD) in adults. Read full article here.
Maladaptive reward memories (MRMs) are involved in the development and maintenance of acquired overconsumption disorders, such as harmful alcohol and drug use. The process of memory reconsolidation – where stored memories become briefly labile upon retrieval – may offer a means to disrupt MRMs and prevent relapse. However, reliable means for pharmacologically weakening MRMs in …